Compounded semaglutide
Sold by Options Medical Weight Loss · every compounded semaglutide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$199
| Medication · Compounded Semaglutide (GLP-1) Injections, 12-month plan paid in full | $199 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Compounded Semaglutide (GLP-1) Injections, 12-month plan paid in full “$199 (per month for a 12-month plan paid in full)” | Per month$199 | Charged today$2,388 |
We earn nothing from this link. Options Medical Weight Loss has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | OptioRx, Columbus OH |
|---|---|
| Cancellation | “We have a 72 hour refund policy, as stated in our membership agreement.” |
Not yet checked: states, prescriber, membership and consult fee.
Recorded from optionsmedicalweightloss.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — Physical clinic chain (multiple US locations) plus a 'Telehealth' nav option; homepage names 'semaglutide (Wegovy)' and 'tirzepatide (Zepbound)' explicitly and advertises a 'Tirzepatide Weight-Loss Program,' but the dedicated Tirzepatide medication page (/medications/trz/) 404s, so no tirzepatide price could be verified despite it clearly being offered. Site also runs a separate credit-based 'membership' system for general clinic services (unrelated dollar figures), distinct from the GLP-1 price found.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.